Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a brain glioma (a type of brain tumour), confirmed by both imaging scans and tissue testing
- People with a life expectancy of more than 3 months
- People who are receiving their first or second round of treatment for this condition
- People who have signed a form giving their informed consent to take part
Who may not be able to join:
- People who do not have a brain glioma diagnosis
- People who have any type of implanted medical device that is powered or controlled by mechanical, electronic, or magnetic means — for example, a pacemaker, cochlear implant, nerve stimulator, or electronic drug pump — as these devices could be affected or stop working properly during the trial
- People who are pregnant or breastfeeding; a urine pregnancy test will be carried out for women who could potentially become pregnant (confirm with trial site for details)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +82230105682
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Documentation of clinical information (demographics and Karnofsky performance score); Documentation of treatment; Documentation of radiologic information of conventional MR imaging and advanced MR imaging
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.